Full List Of Stories
Oxford-AstraZeneca Covid-19 vaccine safe, produces immune response
The coronavirus vaccine being developed by AstraZeneca and the University of Oxford was found to produce both antibodies and T-cells and to be "safe, tolerated, and immunogenic", according to results of a phase 1 human trial published in The Lancet on Monday.
FTSE 100 movers: IAG flies lower; AstraZeneca lifted by vaccine news
London’s FTSE 100 was down 0. 3% at 6,272. 71 in afternoon trade on Monday.
Pfizer, Biontech shares rally on positive Covid vaccine update
Biontech and Pfizer shares rallied on Monday after the companies said preliminary data from their Covid-19 vaccine trial showed that it was able to stimulate antibody and T-cell responses.
DCC shares up with events, says RBC Capital
RBC Capital Markets downgraded its stance on sales, marketing and support services group DCC to ‘sector perform’ from ‘outperform’ on Monday, saying the shares were up with events.
Chevron to buy Noble Energy in $5bn deal
Chevron has agreed to buy Noble Energy in an all-share deal valued at $5bn, or $10. 38 per share.
UK retail footfall loses momentum after initial rush - Springboard
UK retail footfall grew last week but was unable to sustain the double-digit growth seen in the first week following reopening on 4 July.
London midday: Stocks maintain losses amid Covid worries; EU talks in focus
London stocks were still in the red by midday on Monday amid ongoing concerns about a rise in new coronavirus cases in the US and elsewhere, and as EU talks over a rescue fund dragged on.
Pressure on household finances eases a touch in July
Pressure on household finances eased a little in July as the lifting of coronavirus restrictions lent some support but worries about job security grew, according to data released on Monday.
JPMorgan ups UK equities to 'neutral', says risk/reward improving
JPMorgan Cazenove upgraded its stance on UK equities to ‘neutral’ from ‘underweight’ on Monday, highlighting an improvement in risk/reward and funding the move by downgrading Japan equities.
London open: Stocks fall as EU rescue fund talks drag on
London stocks fell in early trade on Monday as EU talks over a rescue fund dragged on, amid ongoing concerns about a rise in new coronavirus cases in the US and elsewhere.
UK government secures 90 million doses of Covid-19 vaccines
The UK government has agreed to buy 90 million doses of coronavirus vaccines being developed by Pfizer and Biontech, and France’s Valneva.
London pre-open: Stocks seen muted as EU rescue fund talks continue
London stocks were on course for a muted open on Monday as talks over an EU coronavirus rescue fund were set to continue.
Monday newspaper round-up: Ted Baker, insurer Covid claims, UK councils
The fashion retailer Ted Baker is to axe at least 500 jobs – more than a quarter of its UK workforce – as the pandemic continues to batter the high street. It is understood that about 200 of the roles will go at the retailer’s London headquarters, the Ugly Brown Building, with the remainder from its shops – it has 46 in the UK and Europe – and store concessions. – Guardian.